Genevieve S Yuen1, Faith M Gunning2, Eric Woods2, Sibel A Klimstra2, Matthew J Hoptman3, George S Alexopoulos2. 1. Weill Medical College of Cornell University, Weill Cornell Institute of Geriatric Psychiatry, NY, USA. Electronic address: gsyuen@med.cornell.edu. 2. Weill Medical College of Cornell University, Weill Cornell Institute of Geriatric Psychiatry, NY, USA. 3. Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA; New York University School of Medicine, New York, NY, USA.
Abstract
BACKGROUND: Apathy is a prominent feature of geriatric depression that predicts poor clinical outcomes and hinders depression treatment. Yet little is known about the neurobiology and treatment of apathy in late-life depression. This study examined apathy prevalence in a clinical sample of depressed elderly, response of apathy to selective serotonin reuptake inhibitor (SSRI) treatment, and neuroanatomical correlates that distinguished responders from non-responders and healthy controls. METHODS: Participants included 45 non-demented, elderly with major depression and 43 elderly comparison individuals. After a 2-week single-blind placebo period, depressed participants received escitalopram 10mg daily for 12 weeks. The Apathy Evaluation Scale (AES) and 24-item Hamilton Depression Rating Scale (HDRS) were administered at baseline and 12 weeks. MRI scans were acquired at baseline for concurrent structural and diffusion tensor imaging of anterior cingulate gray matter and associated white matter tracts. RESULTS: 35.5% of depressed patients suffered from apathy. This declined to 15.6% (p<0.1) following treatment, but 43% of initial sufferers continued to report significant apathy. Improvement of apathy with SSRI was independent of change in depression but correlated with larger left posterior subgenual cingulate volumes and greater fractional anisotropy of left uncinate fasciculi. LIMITATIONS: Modest sample size, no placebo control, post-hoc secondary analysis, use of 1.5T MRI scanner CONCLUSIONS: While prevalent in geriatric depression, apathy is separable from depression with regards to medication response. Structural abnormalities of the posterior subgenual cingulate and uncinate fasciculus may perpetuate apathetic states by interfering with prefrontal cortical recruitment of limbic activity essential to motivated behavior.
BACKGROUND: Apathy is a prominent feature of geriatric depression that predicts poor clinical outcomes and hinders depression treatment. Yet little is known about the neurobiology and treatment of apathy in late-life depression. This study examined apathy prevalence in a clinical sample of depressed elderly, response of apathy to selective serotonin reuptake inhibitor (SSRI) treatment, and neuroanatomical correlates that distinguished responders from non-responders and healthy controls. METHODS:Participants included 45 non-demented, elderly with major depression and 43 elderly comparison individuals. After a 2-week single-blind placebo period, depressedparticipants received escitalopram 10mg daily for 12 weeks. The Apathy Evaluation Scale (AES) and 24-item Hamilton Depression Rating Scale (HDRS) were administered at baseline and 12 weeks. MRI scans were acquired at baseline for concurrent structural and diffusion tensor imaging of anterior cingulate gray matter and associated white matter tracts. RESULTS: 35.5% of depressedpatients suffered from apathy. This declined to 15.6% (p<0.1) following treatment, but 43% of initial sufferers continued to report significant apathy. Improvement of apathy with SSRI was independent of change in depression but correlated with larger left posterior subgenual cingulate volumes and greater fractional anisotropy of left uncinate fasciculi. LIMITATIONS: Modest sample size, no placebo control, post-hoc secondary analysis, use of 1.5T MRI scanner CONCLUSIONS: While prevalent in geriatric depression, apathy is separable from depression with regards to medication response. Structural abnormalities of the posterior subgenual cingulate and uncinate fasciculus may perpetuate apathetic states by interfering with prefrontal cortical recruitment of limbic activity essential to motivated behavior.
Authors: George S Alexopoulos; Charles E Glatt; Matthew J Hoptman; Dora Kanellopoulos; Christopher F Murphy; Robert E Kelly; Sarah S Morimoto; Kelvin O Lim; Faith M Gunning Journal: J Affect Disord Date: 2010-03-25 Impact factor: 4.839
Authors: Liana G Apostolova; Gohar G Akopyan; Negar Partiali; Calen A Steiner; Rebecca A Dutton; Kiralee M Hayashi; Ivo D Dinov; Arthur W Toga; Jeffrey L Cummings; Paul M Thompson Journal: Dement Geriatr Cogn Disord Date: 2007-06-14 Impact factor: 2.959
Authors: Faith M Gunning; Janice Cheng; Christopher F Murphy; Dora Kanellopoulos; Jessica Acuna; Matthew J Hoptman; Sibel Klimstra; Shizuko Morimoto; James Weinberg; George S Alexopoulos Journal: Int J Geriatr Psychiatry Date: 2009-08 Impact factor: 3.485
Authors: Allison C Nugent; Cristan Farmer; Jennifer W Evans; Sam L Snider; Dipavo Banerjee; Carlos A Zarate Journal: Hum Brain Mapp Date: 2019-06-09 Impact factor: 5.038
Authors: Saikat Chakraborty; Jack C Lennon; Sridhar A Malkaram; Yan Zeng; Daniel W Fisher; Hongxin Dong Journal: Neurosci Lett Date: 2019-04-01 Impact factor: 3.046
Authors: Genevieve S Yuen; Saumya Bhutani; Bryony J Lucas; Faith M Gunning; Bassem AbdelMalak; Joanna K Seirup; Sibel A Klimstra; George S Alexopoulos Journal: Am J Geriatr Psychiatry Date: 2014-06-26 Impact factor: 4.105
Authors: Cynthia M Funes; Helen Lavretsky; Linda Ercoli; Natalie St Cyr; Prabha Siddarth Journal: Am J Geriatr Psychiatry Date: 2017-06-16 Impact factor: 4.105
Authors: Harris A Eyre; Prabha Siddarth; Kathleen van Dyk; Natalie St Cyr; Bernhard T Baune; Jorge R Barrio; Gary W Small; Helen Lavretsky Journal: Psychogeriatrics Date: 2017-01-28 Impact factor: 2.440
Authors: Jeffrey N Motter; Gregory H Pelton; Kristina D'Antonio; Sara N Rushia; Monique A Pimontel; Jeffrey R Petrella; Ernst Garcon; Michaela W Ciovacco; Joel R Sneed; P Murali Doraiswamy; Davangere P Devanand Journal: Int J Geriatr Psychiatry Date: 2018-07-23 Impact factor: 3.485